Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF-Reference-Cited by-同舟云学术

Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF

Published:2010-10 Issue:10 Volume:18 Page:1874-1884
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Koski Anniina,Kangasniemi Lotta,Escutenaire Sophie,Pesonen Sari,Cerullo Vincenzo,Diaconu Iulia,Nokisalmi Petri,Raki Mari,Rajecki Maria,Guse Kilian,Ranki Tuuli,Oksanen Minna,Holm Sirkka-Liisa,Haavisto Elina,Karioja-Kallio Aila,Laasonen Leena,Partanen Kaarina,Ugolini Matteo,Helminen Andreas,Karli Eerika,Hannuksela Päivi,Pesonen Saila,Joensuu Timo,Kanerva Anna,Hemminki Akseli

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Clinical trials with oncolytic adenovirus in China;Yu;Curr Cancer Drug Targets,2007

2. Live viruses in cancer treatment;Nemunaitis;Oncology (Williston Park, NY),2002

3. Conditionally replicating adenoviruses for cancer treatment;Jounaidi;Curr Cancer Drug Targets,2007

4. The influence of innate and pre-existing immunity on adenovirus therapy;Zaiss;J Cell Biochem,2009

5. Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy;Qiao;Nat Med,2008

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translation of oncolytic viruses in sarcoma;Molecular Therapy: Oncology;2024-09

2. The investigation of oncolytic viruses in the field of cancer therapy;Frontiers in Oncology;2024-07-10

3. Advances in the therapeutic study of oncolytic virus in colorectal cancer;Oncology and Translational Medicine;2024-07-02

4. Engineering Microorganisms for Cancer Immunotherapy;Advanced Healthcare Materials;2024-04-21

5. Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth;Vaccines;2024-03-21